Prostate artery embolization
Prostate artery embolization is a medical device with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
Embosphere® PROstate Post Market Study
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
Prostate Artery Embolization: Single Center Experience
Clinical Trials (9)
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
Embosphere® PROstate Post Market Study
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
Prostate Artery Embolization: Single Center Experience
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
PROARTE -PROstate ARTery to Reduce the Symptoms of Benign Prostatic Hyperplasia
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9